Cohort
This registry study aims to provide the first 1-year clinical outcomes data for FFRCT management under health insurance coverage.
Coronary computed tomography angiography-derived fractional flow reserve (FFRCT) is useful for noninvasively detecting coronary artery disease. This procedure has been covered by health insurance reimbursement in the United Kingdom, the United States of America, and Japan. This is the first study to investigate the 1-year outcomes of the FFRCT, with management covered by health insurance from the DiscoverY of Novel Assessment Myocardial IsChemia by FFRCT (DYNAMIC-FFRCT) registry.
No takes yet. Share an insight, caveat, or question.
Komiyama et al. (2025) conducted a cohort in Coronary artery disease. Coronary computed tomography angiography-derived fractional flow reserve (FFRCT) was evaluated on 1-year outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: